Year: 2017
Type: article
Abstract: AIMS/HYPOTHESIS: Antenatal obesity and associated gestational diabetes (GDM) are increasing worldwide. While pre-existing insulin resistance is implicated in GDM in obese women, the responsible metabolic pathways remain poorly described. Our aim was to compare metabolic profiles in blood of obese pregnant women with and without GDM 10 weeks prior to and at the time of diagnosis by OGTT. METHODS: We investigated 646 women, of whom 198 developed GDM, in this prospective cohort study, a secondary analysis of UK Pregnancies Better Eating and Activity Trial (UPBEAT), a multicentre randomised controlled trial of a complex lifestyle intervention in obese pregnant women. Multivariate regression analyses adjusted for multiple testing, and accounting for appropriate confounders including study intervention, were performed to compare obese women with GDM with obese non-GDM women. We measured 163 analytes in serum, plasma or whole blood, including 147 from a targeted NMR metabolome, at time point 1 (mean gestational age 17 weeks 0 days) and time point 2 (mean gestational age 27 weeks 5 days, at time of OGTT) and compared them between groups. RESULTS: Multiple significant differences were observed in women who developed GDM compared with women without GDM (false discovery rate corrected p values <0.05). Most were evident prior to diagnosis. Women with GDM demonstrated raised lipids and lipoprotein constituents in VLDL subclasses, greater triacylglycerol enrichment across lipoprotein particles, higher branched-chain and aromatic amino acids and different fatty acid, ketone body, adipokine, liver and inflammatory marker profiles compared with those without GDM. CONCLUSIONS/INTERPRETATION: Among obese pregnant women, differences in metabolic profile, including exaggerated dyslipidaemia, are evident at least 10 weeks prior to a diagnosis of GDM in the late second trimester.
Source: Diabetologia
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,490
Funders: NIHR Bristol Biomedical Research Centre, National Institute for Health and Care Research, Tommy's Baby Charity, Diabetes UK, Chief Scientist Office, King's College London, University of Glasgow, Tommy's, Chief Scientist Office, Scottish Government Health and Social Care Directorate, Medical Research Council, Programme Grants for Applied Research, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: The UPBEAT RCT mother-child study. Stratifying and treating obese pregnant women to prevent adverse pregnancy, perinatal and longer term outcomes., G1235926683, G156065614, G1652070670, NIHR Senior Investigator Award, G2000816325, G2030072381, G2205678033, G3430445556, Improving pregnancy outcome in obese women, G493965252, Metabolomic and Epigenomic Mechanisms in Developmental Overnutrition., Early prediction of Gestational Diabetes Mellitus (GDM) in obese women using clinical characteristics and metabolic biomarkers, G7972533981
OpenAlex ID: W2740283903
